Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The hypercoagulable state in thalassemia.

Amiram Eldor1, Eliezer A Rachmilewitz

  • 1Institute of Hematology, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Blood
|January 5, 2002
PubMed
Summary

Thalassemia patients exhibit a chronic hypercoagulable state, increasing risks of blood clots. This review explores the mechanisms behind this lifelong condition in thalassemia, particularly beta-thalassemia major and intermedia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathophysiology and treatment of patients with beta-thalassemia - an update.

F1000Research·2018
Same author

Iron overload in hematological disorders.

Presse medicale (Paris, France : 1983)·2017
Same author

New Insights on β-Thalassemia in the Palestinian Population of Gaza: High Frequency and Milder Phenotype Among Homozygous IVS-I-1 (HBB: c.92+1G>A) Patients with High Levels of Hb F.

Hemoglobin·2017
Same author

Frequency of silent cerebral ischemia in patients with transfusion-dependent β-thalassemia major compared to healthy individuals.

Annals of hematology·2016
Same author

The frequency of silent cerebral ischemia in patients with transfusion-dependent β-thalassemia major.

Annals of hematology·2015
Same author

The Effect of Fermented Papaya Preparation on Radioactive Exposure.

Radiation research·2015

Area of Science:

  • Hematology
  • Genetics
  • Congenital Disorders

Background:

  • Thalassemia is a congenital hemolytic disorder affecting globin chain synthesis.
  • Chronic blood transfusions, a common treatment, lead to iron overload and organ failure.
  • Improved care has increased life expectancy, revealing new complications like hemostatic changes.

Purpose of the Study:

  • To review the literature on thromboembolic complications in thalassemia.
  • To discuss the mechanisms of the chronic hypercoagulable state in thalassemic patients.
  • To highlight the underemphasized issue of blood clot risks in thalassemia.

Main Methods:

  • Literature review of publications on thromboembolic events and hemostatic anomalies in thalassemia.
  • Analysis of clinical observations in beta-thalassemia major (beta-TM), beta-thalassemia intermedia (beta-TI), and alpha thalassemia (hemoglobin H disease).

Main Results:

  • Thalassemic patients, including those with beta-TM, beta-TI, and hemoglobin H disease, show profound hemostatic changes.
  • A high incidence of thromboembolic events is observed, especially in beta-TI.
  • Prothrombotic anomalies are prevalent even in young patients, indicating a chronic hypercoagulable state.

Conclusions:

  • Thalassemia is associated with a lifelong hypercoagulable state.
  • Understanding these hemostatic changes is crucial for managing thalassemia complications.
  • Further research into the mechanisms of hypercoagulability is warranted.

Related Experiment Videos